Analyst James Mainwaring works at ATLANTIC EQUITIES and is focused on the Healthcare sector with 14 price targets and ratings documented since 2021 spanning on 3 stocks. Analyst's average stock valuation to be materialised ratio is 44.44% with an average time for price targets to be met of 83.33 days.
Most recent stock forecast was given on MDT, Medtronic plc at 01-Jun-2022.
James Mainwaring best performing recommendations are on A (AGILENT TECHNOLOGIES, INC).
The best stock recommendation documented was for A (AGILENT TECHNOLOGIES, INC) at 4/12/2022. The price target of $135 was fulfilled within 127 days with a profit of $10.23 (8.2%) receiving and performance score of 0.65.
Average potential price target upside
Currently, out of the existing stock ratings of James Mainwaring - 867 which are a Hold (84.67%), 157 which are a Buy (15.33%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
170
$35.51 (26.40%)
165
30 days ago
18/22 (81.82%)
$14.06 (17.48%)
226
Buy
174
$39.51 (29.38%)
170
30 days ago
8/13 (61.54%)
$16.78 (15.35%)
111
Hold
170
$35.51 (26.40%)
150
2 months 21 days ago
6/9 (66.67%)
$11.56 (9.60%)
80
Buy
170
$35.51 (26.40%)
160
2 months 25 days ago
10/14 (71.43%)
$11.98 (11.16%)
143
Buy
165
$30.51 (22.69%)
155
4 months 9 days ago
5/7 (71.43%)
$20.86 (15.49%)
116
